Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

210.82
+1.770.85%
Post-market: 210.820.00000.00%17:56 EDT
Volume:1.57M
Turnover:329.02M
Market Cap:10.61B
PE:33.40
High:211.24
Open:208.74
Low:208.47
Close:209.05
52wk High:217.12
52wk Low:138.79
Shares:50.35M
Float Shares:50.35M
Volume Ratio:1.16
T/O Rate:3.11%
Dividend:0.42
Dividend Rate:0.20%
EPS(TTM):6.31
EPS(LYR):-1.4940
ROE:24.54%
ROA:0.10%
PB:1.30
PE(LYR):-141.11

Loading ...

Regeneron Announces Investor Conference Presentations

GlobeNewswire
·
Aug 20

Marvel Biosciences Extends Private Placement Access to Quebec Investors

TIPRANKS
·
Aug 20

Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition

MT Newswires Live
·
Aug 20

Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know

TradingKey
·
Aug 20

US FDA Approves Regeneron's Rare Bone Disorder Drug

Reuters
·
Aug 20

Regeneron Says FDA Approves Pasatru for Adults with Rare Bone Disorder FOP

Reuters
·
Aug 20

Regeneron Pharmaceuticals, - Pasatru Under Review by European Medicines Agency; Global Submissions Planned

THOMSON REUTERS
·
Aug 20

Regeneron Pharmaceuticals, - FDA Approves Pasatru (Garetosmab-Grts) for Adults with Fibrodysplasia Ossificans Progressiva

THOMSON REUTERS
·
Aug 20

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live
·
Aug 19

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19

Movement Alert|iShares Biotechnology ETF Rises 5.1% in Regular Trading, MNC M&A Acceleration and Multiple Catalysts Boost Sector

Market Focus
·
Aug 19

Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb

Dow Jones
·
Aug 19

Femasys announces FDA approval of FemBloc modular premarket approval application

TIPRANKS
·
Aug 19

Ishares Biotech ETF up 3.2%, State Street Spdr S&P Biotech ETF up 2.9%

THOMSON REUTERS
·
Aug 19

BetterLife Pharma Names Mahan Chehrenama Chief Medical Officer

Reuters
·
Aug 19

Amgen Inc : Argus Research Raises Target Price to $460

THOMSON REUTERS
·
Aug 19

Patent Cliffs Drive Pharma Expansion as Biotech M&A and IPO Markets Stage a Comeback

Stock News
·
Aug 19

What This Top Biotech Fund is Buying Now

Dow Jones
·
Aug 19

Percheron Therapeutics Files ASX Corporate Governance Statement and Appendix 4G

TIPRANKS
·
Aug 19

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Disposes of USD 3.86 Million in Common Shares

Reuters
·
Aug 19